EndoTAG-1+GEM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EndoTAG-1+GEM, covering 2023-03-24 to 2023-03-24. Get the full timeline:
Most recent: Clinical Trial Update: EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX [Phase 3]